Nucor
NUE
$221.73
-2.10%
Nucor Corporation is a leading American manufacturer of steel and steel products, operating primarily in the steel industry within the Basic Materials sector. The company is a market leader and a low-cost producer, distinguished by its pioneering use of electric arc furnace (EAF) technology and its unique, decentralized corporate culture. The current investor narrative is driven by a powerful cyclical upswing in the steel market, with recent news highlighting record shipments and strong pricing for peers, fueling debate over whether Nucor's recent stock surge reflects peak-cycle earnings or the beginning of a sustained supercycle supported by infrastructure spending and supply discipline.…
NUE
Nucor
$221.73
Related headlines
Investment Opinion: Should I buy NUE Today?
Rating: Hold. The core thesis is that Nucor is a high-quality operator in a strong cyclical position, but its valuation and technical setup already reflect much of the near-term optimism, creating a balanced risk/reward profile.
Supporting this view, the forward P/E of 14.38x is reasonable for a sector leader, but it hinges on achieving the $17.06 EPS estimate. Revenue growth remains positive at 8.64% YoY in Q4, but the sequential decline is a cautionary signal. Profitability is solid with a net margin of 5.37%, though it has peaked for the cycle. The implied 8.1% upside to the analyst-derived target of $245.30 is not compelling enough to justify a Buy rating given the cyclical risks.
The thesis would upgrade to a Buy if the forward P/E compressed below 12x without a corresponding cut to earnings estimates, or if quarterly revenue and margins re-accelerate, confirming a new leg of the cycle. It would downgrade to a Sell if revenue growth turns negative YoY or if gross margins fall below 10%. Relative to its own history and sector peers, Nucor is fairly valued, not offering a clear margin of safety nor trading at an excessive premium.
Sign up to view all
NUE 12-Month Price Forecast
The outlook is balanced with a slight skew to the base case. Nucor's quality and balance sheet provide a floor, but the stock's dramatic run-up and high beta suggest most near-term optimism is priced in. The key will be the trajectory of Q1 and Q2 2026 earnings—specifically, whether revenue and margins stabilize or continue to decelerate. The stance would upgrade to bullish on evidence of re-accelerating growth and hold on margins; it would turn bearish on a confirmed breakdown of the technical uptrend (below $158) coupled with an earnings miss.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Nucor's 12-month outlook, with a consensus price target around $288.25 and implied upside of +30.0% versus the current price.
Average Target
$288.25
7 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
7
covering this stock
Price Range
$177 - $288
Analyst target range
Nucor is covered by 7 analysts, indicating solid institutional interest. The consensus sentiment leans bullish, with recent actions including reiterated Overweight ratings from Wells Fargo and a Buy from Jefferies, though there have been some cautious moves like Morgan Stanley downgrading to Equal-Weight and UBS moving from Buy to Neutral. The average analyst target price is not explicitly provided in the data, but we can derive an implied target from the average EPS estimate. With an average forward EPS estimate of $17.06 and a forward PE of 14.38x, the implied price target is approximately $245.30, suggesting an upside of about 8.1% from the current price of $227.02. The target range, inferred from EPS estimates, has a low of $15.84 and a high of $18.21, which at the forward PE implies a price range of roughly $227.80 to $261.80. The high target assumes continued strong pricing, volume growth, and perhaps multiple expansion, while the low target likely factors in a quicker-than-expected cyclical downturn or margin compression. The recent mix of ratings—with some downgrades amid the rally—signals that while the trend is recognized, there is growing debate about sustainability, which is typical as a cycle matures.
Bulls vs Bears: NUE Investment Factors
The evidence currently tilts cautiously bullish, but the margin is thin and heavily dependent on the forward earnings outlook. The bull case is anchored by powerful technical momentum, a reasonable forward valuation, and a rock-solid balance sheet. The bear case highlights clear signs of a maturing cycle, including sequential revenue declines and margin compression, alongside high volatility. The single most important tension in the investment debate is whether Nucor's forward earnings estimates of $17.06 per share are achievable. If achieved, the stock appears fairly valued; if missed, the combination of earnings disappointment and multiple compression could lead to significant downside.
Bullish
- Strong Cyclical Momentum: The stock is up 96.62% over the past year and 23.90% over the past three months, significantly outperforming the S&P 500. This powerful uptrend, with the price at 96% of its 52-week high, reflects robust market demand and positive sentiment towards the steel sector.
- Attractive Forward Valuation: The forward P/E of 14.38x is substantially lower than the trailing P/E of 21.58x, indicating the market expects a significant earnings recovery. This forward multiple is more in line with sector averages, suggesting the stock is not egregiously overvalued based on near-term earnings power.
- Robust Balance Sheet: Nucor maintains a fortress-like balance sheet with a low debt-to-equity ratio of 0.34 and a strong current ratio of 2.94. This financial strength provides a significant buffer against cyclical downturns and funds aggressive capital expenditures without excessive leverage.
- Analyst Implied Upside: Based on the average forward EPS estimate of $17.06 and the forward P/E of 14.38x, the implied analyst price target is approximately $245.30. This represents an 8.1% upside from the current price of $227.02, providing a fundamental anchor for the bull case.
Bearish
- Peak Cycle Indicators: Q4 2025 revenue of $7.687B declined sequentially from Q3's $8.521B and Q2's $8.456B, while gross margin compressed to 11.21% from 13.94% and 14.46% in prior quarters. This suggests the cyclical upswing may be maturing, with pricing power and volumes softening.
- High Volatility and Beta: With a beta of 1.884, Nucor is 88.4% more volatile than the broader market. This extreme sensitivity means the stock is highly susceptible to macroeconomic shifts and risk-off sentiment, which could trigger a sharp correction from current elevated levels.
- Negative Free Cash Flow: Trailing twelve-month free cash flow is -$188 million, and Q4 2025 FCF was -$3 million, as heavy capital expenditures ($802M in Q4) consume operating cash flow. This limits near-term shareholder returns and highlights the capital-intensive nature of the business during an investment phase.
- Premium Trailing Valuation: The trailing P/E of 21.58x trades at a premium to typical steel industry multiples, which often range in the low-to-mid teens. This premium prices in near-perfect execution and leaves the stock vulnerable to multiple compression if earnings growth falters.
NUE Technical Analysis
The stock is in a powerful, sustained uptrend, having gained 96.62% over the past year. As of the latest close at $227.02, the price is trading near the top of its 52-week range, approximately 96% of the way from its 52-week low of $106.21 to its high of $235.45. This positioning near all-time highs signals strong momentum but also raises questions about potential overextension, especially given the stock's high beta of 1.884, which indicates it is 88.4% more volatile than the broader market. Recent momentum remains exceptionally strong, with the stock up 19.74% over the past month and 23.90% over the past three months, significantly outpacing the S&P 500's gains of 5.6% and 8.42%, respectively. This acceleration suggests the uptrend is not only intact but gaining steam, with the 1-month relative strength of 14.14 points confirming Nucor's leadership. Key technical levels are clear, with immediate support at the recent pullback low near $158.58 (March 2026) and major support at the 52-week low of $106.21. Resistance is at the recent high and 52-week high of $235.45. A decisive breakout above $235 would signal a continuation of the bull run, while a breakdown below the March low could indicate a deeper correction. The high beta of 1.884 underscores the stock's cyclical and volatile nature, requiring investors to size positions accordingly for the heightened risk.
Beta
1.88
1.88x market volatility
Max Drawdown
-18.4%
Largest decline past year
52-Week Range
$106-$235
Price range past year
Annual Return
+91.4%
Cumulative gain past year
| Period | NUE Return | S&P 500 |
|---|---|---|
| 1m | +13.2% | +3.3% |
| 3m | +20.2% | +6.9% |
| 6m | +50.6% | +12.4% |
| 1y | +91.4% | +23.4% |
| ytd | +30.9% | +7.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
NUE Fundamental Analysis
Nucor's revenue trajectory shows cyclical strength but recent quarterly deceleration. For Q4 2025, revenue was $7.687 billion, representing a solid 8.64% year-over-year growth. However, this marks a sequential decline from Q3's $8.521 billion and Q2's $8.456 billion, indicating a potential peak in the current cycle. Segment data reveals the Steel Mills segment, led by Sheet products ($4.471 billion), is the primary revenue driver, followed by Steel Products and Raw Materials. The company remains solidly profitable, with Q4 2025 net income of $378 million and a net margin of 4.92%. Gross margin for the quarter was 11.21%, a compression from the 13.94% and 14.46% seen in Q3 and Q2 2025, respectively, reflecting potential cost pressures or pricing normalization. The full-year net margin stands at 5.37%, which is healthy for the industry. The balance sheet is robust, with a strong current ratio of 2.94 and a conservative debt-to-equity ratio of 0.34. However, free cash flow generation has been inconsistent, with TTM free cash flow reported at -$188 million, and the latest quarterly free cash flow was -$3 million, as heavy capital expenditures ($802 million in Q4) are consuming operating cash flow ($799 million in Q4). This indicates the company is in a significant investment phase, funding growth internally but with limited excess cash for shareholder returns in the near term.
Quarterly Revenue
$7.7B
2025-12
Revenue YoY Growth
+0.08%
YoY Comparison
Gross Margin
+0.11%
Latest Quarter
Free Cash Flow
$-188000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is NUE Overvalued?
Given Nucor's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing twelve-month PE ratio is 21.58x, while the forward PE is notably lower at 14.38x. This significant gap implies the market expects a substantial rebound in earnings over the next year, aligning with analyst EPS estimates averaging $17.06. Compared to sector averages, Nucor's trailing PE of 21.58x trades at a premium to the typical basic materials/steel industry average, which often ranges in the low-to-mid teens. This premium is likely justified by Nucor's industry-leading position, efficient EAF model, and strong balance sheet, but it also prices in near-perfect execution. Historically, Nucor's own PE ratio has fluctuated widely with the steel cycle. The current trailing PE of 21.58x is above the levels seen during the strong earnings periods of 2021-2022 (often in the 3x-8x range) but below the peak multiples seen during earnings troughs. This suggests the market is valuing Nucor at a mid-cycle level, acknowledging improved earnings but not yet pricing in a cycle peak, leaving room for multiple expansion if the upcycle persists.
PE
21.6x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 3x~38x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on the cyclical nature of earnings and aggressive capital allocation. Sequential revenue declines and gross margin compression from 14.46% in Q2 to 11.21% in Q4 signal potential peak-cycle pressures. While the balance sheet is strong (D/E 0.34), the company is in a heavy investment phase, burning through free cash flow (-$188M TTM) to fund growth, which limits financial flexibility if the cycle turns. Earnings are highly volatile, as evidenced by the wide swing in quarterly EPS from $0.67 in Q1 2025 to $2.63 in Q3 2025.
Market & Competitive Risks are elevated due to Nucor's high beta of 1.884, making it a leveraged bet on economic growth and susceptible to sector rotation out of cyclicals. The stock trades at a premium trailing P/E of 21.58x compared to typical steel peers, creating valuation compression risk if growth expectations moderate. Competitive pressures and potential oversupply in the steel market could further erode pricing power, as hinted by recent news of record shipments from peers like Steel Dynamics, which may signal a peak in industry profitability.
The Worst-Case Scenario involves a rapid cyclical downturn coinciding with a broader market correction. A combination of falling steel prices, volume declines, and compressed margins could drive earnings significantly below current forward estimates. In this adverse scenario, the stock could re-test its 52-week low of $106.21, representing a downside of approximately -53% from the current price of $227.02. A more realistic bear-case target, aligned with the low end of analyst EPS estimates ($15.84) and a compressed multiple of 12x, suggests a downside risk of -16% to around $190.
FAQ
The key risks are, in order of severity: 1) Cyclical Downturn Risk: Evidence includes sequential revenue decline and margin compression (Q4 gross margin 11.21% vs. Q2 14.46%). 2) Volatility Risk: The high beta of 1.884 means NUE will fall sharply in a market correction. 3) Valuation Compression: A premium trailing P/E of 21.58x could contract if growth stalls. 4) Execution Risk: Heavy capex is burning free cash flow (-$188M TTM), requiring projects to deliver future returns.
The 12-month forecast presents three scenarios. The Base Case (50% probability) sees the stock trading between $228 and $245, assuming NUE meets its $17.06 EPS estimate. The Bull Case (30% probability) targets $245 to $262 on stronger-than-expected cycle longevity. The Bear Case (20% probability) warns of a drop to $190-$215 if a downturn hits. The most likely outcome is the Base Case, hinging on the assumption that the current steel cycle plateaus rather than collapses.
NUE is fairly valued. Its trailing P/E of 21.58x is at a premium to the steel sector, justified by its leading position and strong balance sheet. However, its forward P/E of 14.38x, based on expected EPS of $17.06, is more reasonable and in line with sector norms. This valuation implies the market is paying for a strong earnings recovery in the next 12 months. There is no clear margin of safety, nor is the stock egregiously overpriced if earnings targets are met.
NUE is a Hold, not a compelling buy at current levels. For investors already positioned, it's a hold due to its quality and cyclical momentum. For new money, the risk/reward is balanced. The implied 8% upside to analyst targets is modest given the stock's high beta of 1.884 and signs of cyclical peaking, such as sequential revenue declines. It could be a good buy for a tactical, risk-tolerant investor on a significant pullback (e.g., towards $190), but not for a conservative investor seeking stability.
NUE is primarily suitable for medium-term, cyclical investing rather than long-term buy-and-hold or short-term trading. Its high beta and earnings volatility make it a poor fit for short-term traders without a high risk tolerance. For long-term investors, the deep cyclicality requires perfect market timing. The ideal holding period is 12-24 months, aligned with the current phase of the steel cycle, allowing investors to capture the upswing while being prepared to exit before the next downturn.